Unknown

Dataset Information

0

Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection.


ABSTRACT: New strategies to self-assemble biocompatible materials into nanoscale, drug-loaded packages with improved therapeutic efficacy are needed for nanomedicine. To address this need, we developed artificial recombinant chimeric polypeptides (CPs) that spontaneously self-assemble into sub-100-nm-sized, near-monodisperse nanoparticles on conjugation of diverse hydrophobic molecules, including chemotherapeutics. These CPs consist of a biodegradable polypeptide that is attached to a short Cys-rich segment. Covalent modification of the Cys residues with a structurally diverse set of hydrophobic small molecules, including chemotherapeutics, leads to spontaneous formation of nanoparticles over a range of CP compositions and molecular weights. When used to deliver chemotherapeutics to a murine cancer model, CP nanoparticles have a fourfold higher maximum tolerated dose than free drug, and induce nearly complete tumour regression after a single dose. This simple strategy can promote co-assembly of drugs, imaging agents and targeting moieties into multifunctional nanomedicines.

SUBMITTER: MacKay JA 

PROVIDER: S-EPMC2862348 | biostudies-literature | 2009 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection.

MacKay J Andrew JA   Chen Mingnan M   McDaniel Jonathan R JR   Liu Wenge W   Simnick Andrew J AJ   Chilkoti Ashutosh A  

Nature materials 20091108 12


New strategies to self-assemble biocompatible materials into nanoscale, drug-loaded packages with improved therapeutic efficacy are needed for nanomedicine. To address this need, we developed artificial recombinant chimeric polypeptides (CPs) that spontaneously self-assemble into sub-100-nm-sized, near-monodisperse nanoparticles on conjugation of diverse hydrophobic molecules, including chemotherapeutics. These CPs consist of a biodegradable polypeptide that is attached to a short Cys-rich segme  ...[more]

Similar Datasets

| S-EPMC3348377 | biostudies-literature
| S-EPMC9109057 | biostudies-literature
| S-EPMC3024670 | biostudies-literature
| S-EPMC3502577 | biostudies-literature
| S-EPMC8267709 | biostudies-literature
| S-EPMC4991490 | biostudies-literature
| S-EPMC7435236 | biostudies-literature
| S-EPMC4430390 | biostudies-literature
| S-EPMC6915571 | biostudies-literature
| S-EPMC7294693 | biostudies-literature